X

Aarti Pharmalabs Ltd Q3FY24; 10% rise in Profits

Incorporated in 2019, Aarti Pharmalabs Ltd is a manufacturer of Pharmaceuticals and Nutraceuticals

Financial Results:

Aarti Pharmalabs Ltd reported Revenues for Q3FY24 of ₹449.00 Crores down from ₹472.00 Crore year on year, a fall of 4.87%.

Total Expenses for Q3FY24 of ₹376.00 Crores down from ₹406.00 Crores year on year, a fall of 7.39%.

Consolidated Net Profit of ₹53.00 Crores up 10.42% from ₹48.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹5.82, up 10.65% from ₹5.26 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post